◀ Back to JUN
JUN — SP1
Pathways - manually collected, often from reviews:
-
BioCarta keratinocyte differentiation:
c/EBP-alpha (CEBPA)
→
SP1/c-FOS/c-JUN/ETS/c/EBP-alpha complex (SP1-FOS-JUN-ETS2_ETS1-CEBPA)
(modification, collaborate)
-
BioCarta keratinocyte differentiation:
SP1
→
SP1/c-FOS/c-JUN/ETS/c/EBP-alpha complex (SP1-FOS-JUN-ETS2_ETS1-CEBPA)
(modification, collaborate)
-
BioCarta keratinocyte differentiation:
SP1
→
AP-1 complex (FOS-JUN)
(modification, collaborate)
-
BioCarta keratinocyte differentiation:
HOXA7
→
SP1/c-FOS/c-JUN/ETS/c/EBP-alpha complex (SP1-FOS-JUN-ETS2_ETS1-CEBPA)
(modification, inhibits)
-
BioCarta keratinocyte differentiation:
SP1/c-FOS/c-JUN/ETS/c/EBP-alpha complex (SP1-FOS-JUN-ETS2_ETS1-CEBPA)
→
AP-1 complex (FOS-JUN)
(modification, collaborate)
-
BioCarta keratinocyte differentiation:
SP1/c-FOS/c-JUN/ETS/c/EBP-alpha complex (SP1-FOS-JUN-ETS2_ETS1-CEBPA)
→
ETS (ETS2/ETS1)
(modification, collaborate)
-
BioCarta mechanism of gene regulation by peroxisome proliferators via ppara:
PPAR-alpha/Transcription factors complex (PPARA-JUN_RELA_SP1)
→
0005667 (JUN/RELA/SP1/STAT5A/STAT5B)
(modification, collaborate)
-
BioCarta keratinocyte differentiation:
SP1
→
AP-1 complex (FOS-JUN)
(modification, collaborate)
-
FastForward regulation:
SP1
→
JUN
(transcriptional regulation, unknown)
Evidence: DNABINDING
-
FastForward regulation:
SP1
→
JUN
(transcriptional regulation, unknown)
Angel et al., Cell 1988*
Evidence: DNABINDING
-
FastForward regulation:
SP1
→
JUN
(transcriptional regulation, unknown)
Chen et al., Mol Cell Biol 1994*, Rozek et al., Mol Cell Biol 1993*
Evidence: DNABINDING
-
NCI Pathway Database Regulation of nuclear SMAD2/3 signaling:
AP1 complex (FOS-JUN)
→
SMAD2-3/SMAD4/SP1 complex (SMAD2_SMAD3-SMAD4-SP1)
(transcription, activates)
Brodin et al., J Biol Chem 2000
Evidence: mutant phenotype, reporter gene, physical interaction, other species
-
NCI Pathway Database AP-1 transcription factor network:
JUN/JUN-FOS complex (JUN-FOS_JUN)
→
SP1 (SP1)
(transcription, activates)
Scholer et al., Science 1986*, Lee et al., Nature 1987*, Lee et al., Cell 1987*, Haslinger et al., Proc Natl Acad Sci U S A 1985*
Evidence: reporter gene, physical interaction
-
NCI Pathway Database FOXA1 transcription factor network:
AP1 complex (FOS-JUN)
→
SP1 (SP1)
(transcription, activates)
Eeckhoute et al., Genes Dev 2006
Evidence: mutant phenotype, reporter gene, physical interaction
Protein-Protein interactions - manually collected from original source literature:
Studies that report less than 10 interactions are marked with *
Text-mined interactions from Literome
Lim et al., J Virol 2000
(Astrocytoma) :
We postulate that a Tat mediated increase in
SP1 binding activities
augments the binding of
AP1 and NF-kappaB, leading to synergistic activation of the MCP-1 promoter
GarcĂa-Lora et al., Cancer Immunol Immunother 2001
:
Here we report that PSK
enhanced AP-1 and CRE binding activities, whereas IL-2 increased AP-1 and
SP-1 and modified GAS/ISRE, IRF-1 and STAT5
Chamboredon et al., Oncogene 2005
:
Extensive analysis, conducted in CEFs and in Sp1/3-deficient Drosophila SL2 cells, further showed that ( i ) high constitutive activity of -433/+11 requires a direct binding of the ubiquitous
Sp1 and/or Sp3 transcription factors acting on two distinct motifs, that is, a proximal TCC-rich region and an upstream GC box, and that ( ii ) repression by
v-Jun does not
require any direct binding of the oncoprotein to the DNA, but an indirect binding within a v-Jun-Sp1/3-DNA chromatin associated complex
Xing et al., J Cell Mol Med 2009
:
These findings indicate that the up-regulation of the eNOS gene transactivity by LPC involves the
enhancement of
SP1 transcription factor by the activation of JNK and ERK1/2 signalling pathways and
AP1 transcription factor by the activation of JNK signalling pathway
Clerc et al., Virology 2009
:
In conclusion, we demonstrate that the repression of c-Jun activity in vivo is mainly due to the
HBZ-SP1 mediated sequestration of
c-Jun to the HBZ-NBs
Chai et al., Hepatology 2012
(Cholestasis...) :
In HepG2 cells, TNFa treatment
induced SP1 and MRP3/ABCC3 expression in a dose- and time dependent manner, where increased phosphorylation of
c-Jun NH2-terminal kinase/stress activated protein kinase ( JNK/SAPK ) was also detected